Clinical Trial Update: Immunotherapy with Autologous Tregs in T1DM [Phase 1]

View source ↗

Summary

A phase 1 clinical trial evaluating autologous regulatory T cell immunotherapy for type 1 diabetes mellitus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Autologous regulatory T cell immunotherapy

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: RECRUITING